The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / Sequencing Improves Lung Infection Diagnosis
Microbiology & Immunology Omics Precision medicine Technology and innovation Infectious Disease

Sequencing Improves Lung Infection Diagnosis

Study of 941 patients highlights how next-generation sequencing can identify difficult-to-detect pathogens and guide antimicrobial treatment

11/10/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

5 Key Takeaways
  • 1

    In a retrospective study of 941 patients with suspected lower respiratory tract infections, both metagenomic and targeted NGS had greater diagnostic yield than conventional microbiological testing.

  • 2

    Metagenomic NGS sensitivity was 90.6%, compared with 73.4% for targeted NGS, but the methods were evaluated in separate patient groups.

  • 3

    Targeted NGS identified 54 cases of Mycobacterium tuberculosis, including 42 missed by conventional testing, and detected Pneumocystis jirovecii when silver staining was negative.

  • 4

    After targeted NGS results, 22.6% of patients required antimicrobial treatment escalation, and 66.2% showed clinical improvement, similar to 66.7% with initially appropriate treatment.

  • 5

    Both sequencing approaches had low specificity, and the retrospective, single-center study could not establish that sequencing-guided treatment caused improved outcomes.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.